Digirad Co. (NASDAQ:DRAD) reached a new 52-week high and low on Thursday . The company traded as low as $1.35 and last traded at $1.36, with a volume of 152759 shares changing hands. The stock had previously closed at $1.45.
Separately, ValuEngine downgraded Digirad from a “buy” rating to a “hold” rating in a report on Sunday, December 31st.
The company has a debt-to-equity ratio of 0.70, a current ratio of 1.51 and a quick ratio of 1.18.
Digirad (NASDAQ:DRAD) last released its quarterly earnings data on Friday, February 23rd. The medical equipment provider reported ($0.14) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.19). The company had revenue of $30.92 million for the quarter. Digirad had a negative net margin of 30.19% and a positive return on equity of 0.32%.
In other Digirad news, major shareholder Cannell Capital Llc bought 65,508 shares of Digirad stock in a transaction dated Tuesday, January 23rd. The shares were acquired at an average cost of $2.65 per share, with a total value of $173,596.20. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Matthew G. Molchan bought 25,000 shares of Digirad stock in a transaction dated Wednesday, February 28th. The stock was acquired at an average cost of $2.14 per share, for a total transaction of $53,500.00. Following the completion of the acquisition, the insider now directly owns 77,819 shares in the company, valued at $166,532.66. The disclosure for this purchase can be found here. 11.90% of the stock is currently owned by insiders.
Several institutional investors and hedge funds have recently made changes to their positions in DRAD. Ariel Investments LLC boosted its holdings in shares of Digirad by 91.7% in the 4th quarter. Ariel Investments LLC now owns 1,222,819 shares of the medical equipment provider’s stock worth $3,149,000 after acquiring an additional 584,777 shares in the last quarter. Macquarie Group Ltd. acquired a new position in shares of Digirad in the 3rd quarter worth approximately $367,000. Heartland Advisors Inc. boosted its holdings in shares of Digirad by 10.0% in the 4th quarter. Heartland Advisors Inc. now owns 970,605 shares of the medical equipment provider’s stock worth $2,499,000 after acquiring an additional 88,134 shares in the last quarter. Finally, New York State Common Retirement Fund boosted its holdings in shares of Digirad by 22.0% in the 3rd quarter. New York State Common Retirement Fund now owns 172,901 shares of the medical equipment provider’s stock worth $597,000 after acquiring an additional 31,200 shares in the last quarter. 56.14% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Digirad (DRAD) Sets New 1-Year High and Low at $1.35” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/04/07/digirad-drad-sets-new-1-year-high-and-low-at-1-35.html.
Digirad Corporation provides healthcare solutions in the United States. It operates through Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging segments. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services, as well as offers remote cardiac event monitoring services.
Receive News & Ratings for Digirad Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Digirad and related companies with MarketBeat.com's FREE daily email newsletter.